Overview

Secretin Infusion for Pain Due to Chronic Pancreatitis

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
- To determine if intravenous secretin administration in escalating doses three times daily for three days will improve the pain from CP at the time of infusion, after each infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion. - To validate the safety of intravenous secretin administration at the dosage indicated in this study.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ChiRhoClin, Inc.
Collaborator:
Dartmouth-Hitchcock Medical Center
Treatments:
Secretin